About Elder Pharmaceuticals Limited
Data last updated:
Elder Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 April 1983.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24239MH1983PLC029714. The company has 24 GST registrations on record, none of which is active. It is a listed company.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹20.54 Cr. It is led by directors including Alok Jagdish Saxena (Managing Director) and Abdul Khader Mohammed Ravani.
Its last annual general meeting (AGM) was held on 30 December 2013, and its latest financial statements are for the year ended 30 June 2013. The registered office is at Elder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, India – 400058.
As per the financials filed for FY 2013, the company reported a revenue of ₹1,259.31 Cr, a growth of 25% compared to the previous year.
As per MCA filings, the company has open charges of ₹338.1 Cr and satisfied charges of ₹3,335.92 Cr on record. Court records list 972 cases involving the company, including 278 filed by the company and 663 filed against it; 105 cases are pending. The company has 36 deals on record (32 market trades, 2 acquisitions, 1 qip), with disclosed funding of ₹38.66 Cr; the latest was in January 2015. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Onesource Specialty Pharma Limited with revenue of ₹1,462.33 Cr.
The last known website on record is elderindia.com.
CIN History of Elder Pharmaceuticals Limited
Elder Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1983PLC029714. The current CIN is L24239MH1983PLC029714, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24239MH1983PLC029714 | Current |
| U24239MH1983PLC029714 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressElder House Plot No C9Dalia Industrial Estate Off Veera Desai Road Andheri W India, Mumbai, Maharashtra, India – 400058
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Elder Pharmaceuticals Limited FY 2013 filings available
Elder Pharmaceuticals Limited reported revenue of ₹1,259.31 Cr (up 25% YoY) for FY 2013.
Compounded Annual Growth Rate (CAGR) of Elder Pharmaceuticals Limited
Revenue rose 25% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Elder Pharmaceuticals Limited
| Metrics | FY 2012-13 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Elder Pharmaceuticals Limited
| Metrics | FY 2012-13 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elder Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elder Pharmaceuticals Limited
Elder Pharmaceuticals has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Jagdish Saxena | Managing Director | 29 Aug 2002 | 24 Years 1 Months | As last reported |
| Abdul Khader Mohammed Ravani | Additional Director | 25 Jan 2016 | 10 Years 8 Months | As last reported |
| Kader Mohamed Davawala | Additional Director | 25 Jan 2016 | 10 Years 8 Months | As last reported |
Peer Comparison of Elder Pharmaceuticals Limited
Elder Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Onesource Specialty Pharma Limited | ₹1,462.33 Cr (FY 2025) | •••• | •••• | 730.0% | •••• | Thane, Maharashtra, India |
| Par Formulations Private Limited | ₹1,462.09 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Chennai, Tamil Nadu, India |
| Encube Ethicals Private Limited | ₹1,369 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Mumbai, Maharashtra, India |
| Shasun Pharmaceuticals Limited | ₹1,328.86 Cr (FY 2015) | •••• | •••• | 8.0% | •••• | Chennai, Tamil Nadu, India |
| Sentiss Pharma Private Limited | ₹1,262.74 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | New Delhi, Delhi, India |
| Elder Pharmaceuticals Limited this company | ₹1,259.31 Cr (FY 2013) | •••• | •••• | 25.0% | •••• | Mumbai, Maharashtra, India |
| Innova Captab Limited | ₹1,255.72 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Thane, Maharashtra, India |
| Mylan Pharmaceuticals Private Limited | ₹1,253.34 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Cipla Health Limited | ₹1,228.87 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Neon Laboratories Limited | ₹1,222.81 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Corona Remedies Limited | ₹1,202.35 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Elder Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Elder Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2014 | Dcb Bank Limited | ₹16 Cr | Open |
| 30 Jul 2014 | Bank of India | ₹35 Cr | Open |
| 19 Nov 2012 | Axis Trustee Services Limited | ₹70 Cr | Open |
| 28 Jun 2011 | Axis Trustee Services Limited | ₹73 Cr | Open |
| 21 Mar 2011 | Axis Trustee Services Limited | ₹118.8 Cr | Open |
Total charge records: 176 View all charges
Deals & Funding of Elder Pharmaceuticals Limited
Elder Pharmaceuticals Limited has 36 deals on record (32 market trades, 2 acquisitions, 1 qip), with disclosed funding of ₹38.66 Cr; the latest was in January 2015.
Deals on record (5 of 36)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2015 | Market trade | ₹3.2 Cr | Buyer: Millennium Stock Broking Private Limited Seller: Millennium Stock Broking Private Limited |
| Mar 2014 | Market trade | ₹2.39 Cr | Buyer: Monet Securities Pvt. Ltd. Seller: Supreme Wood Products Pvt Ltd |
| Jan 2014 | Market trade | ₹2.74 Cr | Buyer: Crosseas Capital Markets Private Limited Seller: Crosseas Capital Markets Private Limited |
| Dec 2013 | Acquisition | ₹2,004 Cr | Buyer: Torrent Pharmaceuticals Ltd Seller: Elder Pharmaceuticals Limited |
| Dec 2013 | Market trade | ₹6.61 Cr | Buyer: Crosseas Capital Markets Private Limited Seller: Crosseas Capital Markets Private Limited |
Full deal history
All 36 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Elder Pharmaceuticals Limited
Elder Pharmaceuticals Limited has 972 court cases on record: 278 filed by Elder Pharmaceuticals, 663 filed against it, 31 where it is another party. 105 cases are pending and 867 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 582 | 360 | 26 |
| District courts | 390 | 303 | 79 |
Cases on record (5 of 972)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Madras High Court | Court case ((T)OP(TM)) | Filed by the company against Uniorange Life Care Private Limited | Pending |
| Bombay High Court | Court case (JO) | Filed against the company by Ranisati Merchandise Pvt Ltd | Pending |
| Bombay High Court | Court case (JO) | Filed against the company by Sonali Suppliers Pvt Ltd | Pending |
| Bombay High Court | Court case (JO) | Filed against the company by Vidhan Sales Agencies Pvt.Ltd. | Pending |
| Bombay High Court | Court case (JO) | Filed against the company by Shivarpan Vanijya Pvt Ltd | Pending |
Full case history
All 972 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Elder Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Elder Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Elder Pharmaceuticals Limited
Elder Pharmaceuticals Limited has 37 board changes on record since 1983: 20 appointments and 17 cessations. The latest: Abdul Khader Mohammed Ravani was appointed as Additional Director on 25 Jan 2016.
431 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Elder Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elder Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elder Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elder Pharmaceuticals Limited
Elder Pharmaceuticals has 24 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elder Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elder Pharmaceuticals Limited
Elder Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Elder Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 April 1983 and is registered under CIN L24239MH1983PLC029714. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Elder Pharmaceuticals reported revenue of ₹1,259.31 Cr for FY 2013 (up 25% YoY).
Elder Pharmaceuticals has 3 current directors:
- Alok Jagdish Saxena - Managing Director
- Abdul Khader Mohammed Ravani - Additional Director
- Kader Mohamed Davawala - Additional Director
The CIN (Corporate Identification Number) of Elder Pharmaceuticals is L24239MH1983PLC029714. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes, Elder Pharmaceuticals is a listed company.
Elder Pharmaceuticals has open charges of ₹338.1 Cr and satisfied charges of ₹3,335.92 Cr as per latest MCA filings.
Elder Pharmaceuticals has 972 court cases on record: 278 filed by the company and 663 filed against it. 105 are pending. Most are in the high courts.
Elder Pharmaceuticals was incorporated on 02 April 1983. It is registered with the Registrar of Companies, Mumbai.
Elder Pharmaceuticals has 36 deals on record (32 market trades, 2 acquisitions, 1 qip), with disclosed funding of ₹38.66 Cr; the latest was in January 2015.
The peers of Elder Pharmaceuticals by revenue are Onesource Specialty Pharma Limited, Par Formulations Private Limited, Encube Ethicals Private Limited, Shasun Pharmaceuticals Limited, Sentiss Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).